Why is Aarti Drugs falling/rising?

As of 01-Aug, Aarti Drugs Ltd is currently priced at 490.65, reflecting a decline of 15.9 points or 3.14%. The stock has been experiencing a downward trend, having fallen for the last three consecutive days, resulting in a total return of -8.94% during this period. Today's trading saw the stock reach an intraday low of Rs 486, and the volume traded was higher near this low price. Despite this decline, the company shows strong fundamentals with high management efficiency indicated by a return on capital employed (ROCE) of 17.84% and a low debt-to-equity ratio of 0.45. Although the stock has generated a negative return of -2.87% over the past year, its profits have increased by 20.4%, suggesting that the stock is trading at a discount compared to its peers. In the broader market context, Aarti Drugs' short-term performance has been notably worse than the benchmark Sensex, which has only declined by 1.06% over the past week while Aarti Drugs has dropped by 7.95%. The pharmaceuticals and drugs sector as a whole has also seen a decline of 3.27%, contributing to the stock's downward movement. However, there has been a rise in investor participation, with delivery volume increasing by 33.6% against the five-day average, indicating some level of interest despite the recent price drop. Overall, while the stock faces short-term challenges, its underlying financial health and valuation metrics suggest potential for recovery in the longer term.